🔎 Trials Near Me

Utama › Glioma › Maryland

Kajian klinikal Glioma di Maryland

11 kajian untuk Glioma sedang mencari peserta di lokasi di Maryland.

Bandar di Maryland

Teks kajian rasmi (Bahasa Inggeris)

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

  • Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Mengambil pesertaFasa 1/2
12 Months – 21 Years · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05099003

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • Johns Hopkins Sidney Kimmel Cancer Center - Baltimore, Baltimore
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07326566

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

  • National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa 1/2
Umur 18 hingga 99 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07416188

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

  • National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa 1/2
Umur 15 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT05588141

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

  • John Hopkins University, Baltimore
Mengambil pesertaFasa 1
Umur 1 hingga 25 · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT04485559

Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

  • National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa 1
Umur 18 hingga 120 · Semua jantina · Dikemas kini 14 Ogo 2026 · NCT06344130

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

  • National Institutes of Health Clinical Center, Bethesda
Mengambil pesertaFasa 1/2
Umur 18 hingga 120 · Semua jantina · Dikemas kini 12 Ogo 2026 · NCT06161519

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • The John Hopkins Hospital, Baltimore
  • Maryland Oncology Hematology- Columbia, Rockville
Mengambil pesertaFasa 2
Umur 8 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT05503797

LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)

  • Maryland Proton Treatment Center, Baltimore
  • University of Maryland Greenebaum Cancer Center, Baltimore
  • UCH Kaufman Cancer Center, Bel Air
  • dan 2 lagi
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2026 · NCT04699773

Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms

  • National Institutes of Health, Bethesda
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Dis 2025 · NCT04541082

Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating Gliomas

  • Rosy Njonkou Tchoquessi, Baltimore
Mengambil pesertaFasa 1
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2025 · NCT04772456

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.